Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Neoplasms, Germ Cell and Embryonal 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Cisplatin 8Etoposide 7Bleomycin 6Ifosfamide 5Carboplatin 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3liposomal amphotericin B 2Vinblastine 2Radiotherapy 2Filgrastim 2Cyclophosphamide 2sodium thiosulfate 1etoposide phosphate 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Ribavirin 1Restraint, Physical 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Palivizumab 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Congresses as Topic 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Teratoma × Respiratory Physiological Phenomena × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡